📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. (2024)

First Author: Deanfield J

Attributed to: Precision medicine for diabetic Individuals: a joint Malaysia-UK Effort (PRIME) project funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(24)01498-3

PubMed Identifier: 39181597

Publication URI: http://europepmc.org/abstract/MED/39181597

Type: Journal Article/Review

Volume: 404

Parent Publication: Lancet (London, England)

Issue: 10454

ISSN: 0140-6736